CLEVELAND--Bioinformatics software company NetGenics here has announced an agreement with Gene Codes to integrate the Unix version of Gene Codes' popular Sequencher DNA seqencing program into NetGenics' CORBA-based Synergy drug discovery platform. Sequencher will be added to Synergy's server and its functionality can be accessed through Synergy's graphical user interface.
"We're pleased to have this opportunity to deliver the Sequencher technology to our pharmaceutical industry users on an enterprise-wide basis through Synergy," commented Howard Cash, Gene Codes' president. "As a widely accepted standard for DNA sequence assembly, Sequencher will enhance Synergy's attractiveness to the research biologist. It is encouraging to see that the demand for Sequencher and the interest in Synergy have created this natural partnership."
"The addition of Sequencher highlights the strength of Synergy's framework technology and the importance of moving toward open standards for bioinformatics," added Manuel Glynias, NetGenics' president and CEO. "Synergy was specifically designed to allow the easy incorporation of a wide variety of information tools for drug discovery, including those used for sequence analysis and assembly."
According to NetGenics, Synergy offers a modular framework that permits the integration of legacy, proprietary, and third-party data and software into its package. This flexibility makes Synergy especially valuable for bioinformatics environments that require the interconnection of numerous different data formats.